Durham researchers play key role in breast cancer study with AI-VISION
- 19 minutes ago
- 1 min read
Scientists from Durham University's top-rated Physics Department are playing a key role in a new UK clinical study aimed at improving treatment for people with triple-negative breast cancer (TNBC), a fast-growing form of the disease.
The project, known as AI-VISION, brings together cancer specialists, data scientists and physicists to harness cutting-edge technologies to learn more about why some patients respond well to treatment and others do not.
The study has secured a significant £1 million grant from Innovate UK, part of UK Research and Innovation, to fund work that could transform how treatment decisions are made for TNBC patients.
